Boundless Bio's corporate headquarters is located at:
10955 Alexandria Way, Suite 100
San Diego, CA 92121
Boundless Bio is incorporated in the state of Delaware.
The initial public offering (IPO) occurred on March 28, 2024.
The fiscal year end is December 31.
Boundless Bio is traded on the NASDAQ Global Select Market under the ticker symbol “BOLD”, and our CUSIP number is 10170A 100.
No, Boundless Bio does not pay a dividend.
The transfer agent and registrar for the common stock is Computershare Trust Company, N.A. The transfer agent and registrar’s address is 150 Royall Street, Canton, MA 02021.
Boundless Bio’s independent registered public accounting firm is KPMG LLP.
Boundless Bio’s legal counsel is Lathem & Watkins LLP.
SEC filings can be found at on our SEC Filings page and on the SEC website.
Additional investor queries can be directed to Boundless Bio by contacting investors@boundlessbio.com.